Loading...
OTC: ESLOY
EssilorLuxottica S.A.
Healthcare · Medical - Instruments & Supplies
Market Cap
$105.69B
52w High
$186.81
52w Low
$113.90
P/E
39.76
Volume
3.28K
Outstanding Shares
920.92M
Valuation Data Insufficient
The DCF model's fair value estimate is more than 3× the current stock price. This typically indicates unreliable model inputs — such as irregular cash flows or balance sheet distortions — rather than a genuine opportunity, so the valuation is not shown.
Company profile
EssilorLuxottica Société anonyme designs, manufactures, and distributes ophthalmic lenses, frames, and sunglasses in North America, Europe, Latin America, Asia, Oceania, and Africa.
CEOFrancesco Milleri
SectorHealthcare
IndustryMedical - Instruments & Supplies
Employees153,498
IPO dateJan 30, 2008
Valuation
Forward P/E—
EV/EBITDA22.08
Enterprise value$137.28B
Stock splits
Jul 24, 20072:1
Profitability & growth
Revenue growth14.48%
Gross margin60.56%▼4.48%vs FY2024
Operating margin11.8%▼9.31%vs FY2024
ROE5.72%▼2.09%vs FY2024
Analyst consensus
RatingHold
Target price—
0
Buy
1
Hold
0
Sell
⚠ Analyst ratings tend to be lagging indicators — upgrades often follow price gains rather than precede them. Use as one signal among many.
Earnings
Last 3 reported quarters plus the next estimate. Switch into compare mode to inspect one metric year-over-year.
Next report
Jul 28, 2026
View
EPS
Actual vs estimate by quarter
Q4'24
ActualEst.
$1.12
$1.45
Q2'25
ActualEst.
$1.77
$2.29
Q4FY25
ActualEst.
$1.15
$1.57
Q1FY26
Next Est.
—
Revenue
Actual vs estimate by quarter
Q4'24
ActualEst.
$13.69B
$13.54B
Q2'25
ActualEst.
$16.51B
$16.17B
Q4FY25
ActualEst.
$16.87B
$16.31B
Q1FY26
Next Est.
—